The US government has selected five companies as leading contenders to produce an effective vaccine,There are more than 130 potential coronavirus vaccines in development, with the vast majority yet to start human testing. Business Insiderthat are expected to start clinical trials in 2020.
Moderna has started dosing volunteers in a second trial, randomizing 600 people to receive either the vaccine or a placebo. The biotech is also planning to start in July a 30,000-person late-stage study. to accelerate the vaccine and ramp up production. The agency is aiming to be ready to start delivering doses in October. The money will help produce at least 300 million doses, BARDA stated.
Mikael Dolsten, Pfizer's chief scientific officer, told Business Insider in an interview the trial could allow for emergency use or accelerated approval this fall, depending on the situation. On May 26, Merck made public its coronavirus vaccine efforts, aiming to have two experimental vaccines start trials before year's end.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »